Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearnings

Halozyme Therapeutics, Inc. News

Biotechs Weakened by The Stock Market Rout

Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.

Who Will Survive?: Cramer's 'Mad Money' Recap (Thursday 5/14/20)

Jim Cramer says many companies aren't prepared for extended shutdowns and they may not be able to get the credit they need to survive.

It's Bad, But It's Not a Crash: Cramer's 'Mad Money' Recap

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

Roku, Sierra Wireless, Visa, Cimarex Energy: 'Mad Money' Lightning Round

Jim Cramer focuses on Roku, Sierra Wireless, Visa, Cimarex Energy, First Solar, Halozyme Therapeutics.

Breaking News

Twitter Stock Leaps As Elon Musk Adds More Equity To $44 Billion Takeover Bid, Closes Tesla Margin Loan

Elon Musk has closed out his margin loans, linked to Tesla shares, and pledged another $6.25 billion in equity to fund his $44 billion takeover of the social media website.

Nvidia Stock: Investors Are Buying the Dip. Where From Here?

Nvidia stock is being bought on the dip. Here's how traders should approach it now.

Macy's Stock Soars On Q1 Earning Beat, 2022 Profit Forecast Boost As Shoppers Defy Inflation Gloom

"While macroeconomic pressures on consumer spending increased during the quarter, our customers continued to shop," said CEO Jeff Gennette.

Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal

"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.